IMVT Immunovant, Inc. - Common Stock
$44.97
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
52周区间
$14–$45
99% of range
分析师评级
STRONG BUY
22 analysts
目标价
$48
+6% upside
P/E (TTM)
-16.2
ROE
-73.7%
净利润率
—
IMVT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$44.97
市值
$9.17B
P/E (TTM)
-16.2
每股收益 (TTM)
$-2.77
营收 (TTM)
—
股息收益率
—
ROE
-73.7%
负债/权益
—
52周区间
$14 – $45
IMVT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
—
EPS
$-2.77
2021-03-31
→
2026-03-31
自由现金流
$-407M
2020-03-31
→
2026-03-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
IMVT
同行中位数
P/E (TTM)
-16.2
16.0
P/S (TTM) (市销率 (TTM))
469.9
32.5
P/B (市净率)
10.8
3.9
Price / FCF (股价/自由现金流)
-22.5
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
IMVT
同行中位数
ROA
-58.3%
-22.2%
ROE
-73.7%
-37.6%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
IMVT
同行中位数
Current Ratio (流动比率)
9.1
5.7
Quick Ratio (速动比率)
8.6
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
IMVT
同行中位数
Revenue YoY (营收同比增长)
229.2%
—
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
IMVT
同行中位数
IMVT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
22 位分析师
- 强烈买入 9 40.9%
- 买入 9 40.9%
- 持有 4 18.2%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
16 位分析师 · 2026-08-17
中位数
$48.50
现在
$44.97
最低
$24.00
最高
$66.00
中位数目标
$48.50
+7.9%
平均目标
$47.88
+6.5%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
Beat Rate
25.0%
平均惊喜
-0.03%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2027年3月31日 | $-0.75 | $-0.63 | -0.12% |
| 2026年12月31日 | $-0.73 | $-0.61 | — |
| 2026年6月30日 | $-0.75 | $-0.63 | -0.12% |
| 2026年3月31日 | $-0.73 | $-0.61 | -0.12% |
| 2025年12月31日 | $-0.61 | $-0.73 | 0.12% |
| 2025年9月30日 | $-0.73 | $-0.73 | 0.00% |
| 2025年6月30日 | $-0.71 | $-0.66 | -0.05% |
| 2025年3月31日 | $-0.64 | $-0.73 | 0.09% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | — |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | — |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | — |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 12
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | $102M | $69M | $48M | $26M | |
| SG&A Expense | $76M | $77M | $57M | $48M | $54M | $40M | $18M | $3M | |
| Operating Expenses | $533M | $438M | $283M | $218M | $156M | $108M | $66M | $28M | |
| Interest Expense | · | · | · | · | · | $0 | $625.0K | · | |
| Other Non-op | $2M | $471.0K | $-1M | $-253.0K | $-781.0K | $328.0K | $412.0K | $-155.0K | |
| Pretax Income | $-505M | $-413M | $-259M | $-211M | $-157M | $-108M | $-66M | $-29M | |
| Income Tax | $215.0K | $891.0K | $567.0K | $9.0K | $-84.0K | $-358.0K | $97.0K | $19.0K | |
| Net Income | $-506M | $-414M | $-259M | $-211M | $-157M | $-107M | $-66M | $-29M | |
| EPS (Basic) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · | |
| EPS (Diluted) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · | |
| Shares (Basic) | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · | |
| Shares (Diluted) | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · |
资产负债表 19
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $902M | $714M | $635M | $377M | $494M | $400M | $101M | $7M | |
| Receivables | $1M | $2M | $5M | $700.0K | $12M | $596.0K | · | · | |
| Prepaid Expense | $46M | $51M | $25M | $27M | $6M | $8M | $5M | $3M | |
| Current Assets | $949M | $768M | $666M | $404M | $513M | $409M | $109M | $13M | |
| PP&E (Net) | $443.0K | $844.0K | $462.0K | $333.0K | $330.0K | $201.0K | $65.0K | $54.0K | |
| Other Non-current Assets | $8M | $8M | $0 | · | · | · | · | · | |
| Total Assets | $957M | $776M | $666M | $406M | $516M | $412M | $109M | $14M | |
| Accounts Payable | $8M | $18M | $7M | $1M | $19M | $2M | $1M | $206.0K | |
| Accrued Liabilities | $97M | $51M | $41M | $40M | $25M | $15M | $11M | $6M | |
| Current Liabilities | $104M | $69M | $49M | $43M | $45M | $19M | $15M | · | |
| Capital Leases | · | · | $0 | $47.0K | $1M | $2M | $0 | · | |
| Total Liabilities | $104M | $69M | $49M | $43M | $46M | $21M | $15M | $6M | |
| Common Stock | $20.0K | $16.0K | $14.0K | $13.0K | $12.0K | $10.0K | $5.0K | $4.0K | |
| Paid-in Capital | $2.60B | $1.95B | $1.44B | $928M | $825M | $590M | $185M | $32M | |
| Retained Earnings | $-1.75B | $-1.24B | $-826M | $-566M | $-355M | $-199M | $-91M | $-25M | |
| AOCI | $730.0K | $1M | $2M | $852.0K | $404.0K | $-298.0K | $-16.0K | $346.0K | |
| Stockholders' Equity | $853M | $707M | $618M | $362M | $470M | $391M | $94M | $7M | |
| Liabilities + Equity | $957M | $776M | $666M | $406M | $516M | $412M | $109M | $14M | |
| Shares Outstanding | 203,940,353 | 170,111,593 | 145,582,999 | 130,329,863 | 116,482,899 | 97,971,243 | 54,655,376 | 38,590,381 |
现金流 12
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $56M | $49M | $41M | $32M | $34M | $19M | $7M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-407M | $-376M | $-214M | $-188M | $-106M | $-83M | $-53M | $-29M | |
| CapEx | $8.0K | $759.0K | $360.0K | $197.0K | $254.0K | $210.0K | $31.0K | $52.0K | |
| Investing Cash Flow | $-8.0K | $-759.0K | $-360.0K | $-197.0K | $-254.0K | $-210.0K | $-31.0K | $-52.0K | |
| Stock Issued | $544M | $450M | $473M | · | · | · | · | $15M | |
| Net Stock Activity | $544M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $596M | $454M | $472M | $71M | $200M | $383M | $147M | $36M | |
| Net Change in Cash | $188M | $79M | $259M | $-117M | $94M | $300M | $94M | $7M | |
| Taxes Paid | $2M | · | $509.0K | $0 | · | · | · | · | |
| Free Cash Flow | $-407M | $-377M | $-215M | $-188M | $-106M | $-84M | $-53M | · | |
| Levered FCF | · | · | · | · | · | $-84M | $-54M | · |
盈利能力 4
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | -1039.5% | -2783.8% | · | · | · | · | |
| Pretax Margin | · | · | -1037.2% | -2783.7% | · | · | · | · | |
| ROA | -58.3% | -57.4% | -48.4% | -45.8% | -33.8% | -41.2% | -107.8% | · | |
| ROE | -73.7% | -78.1% | -40.0% | -54.3% | -32.1% | -26.7% | -64.5% | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.1 | 11.2 | 13.7 | 9.3 | 11.5 | 21.8 | · | · | |
| Quick Ratio | 8.6 | 10.4 | 13.2 | 8.7 | 11.4 | 21.3 | · | · |
效率 2
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | 8.3 | 1.2 | · | · | · | · |
增长率 1
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 229.2% | · | · | · | · | · |
估值 (TTM) 10
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $25M | $8M | $0 | · | · | · | |
| Net Income TTM | $-506M | $-414M | $-259M | $-211M | $-157M | $-107M | $-66M | · | |
| Market Cap | $5.07B | $2.91B | $4.70B | $2.02B | $642M | $1.57B | $851M | · | |
| P/E | -9.0 | -6.3 | -17.2 | -9.1 | -3.9 | -13.1 | · | · | |
| P/S | 259.6 | 149.0 | 188.5 | 266.7 | · | · | · | · | |
| P/B | 5.9 | 4.1 | 7.6 | 5.6 | 1.4 | 4.0 | 9.0 | · | |
| P / Tangible Book | 5.9 | 4.1 | 7.6 | 5.6 | 1.4 | 4.0 | · | · | |
| P / Cash Flow | -12.4 | -7.7 | -22.0 | -10.7 | -6.0 | -18.9 | -15.9 | · | |
| P / FCF | -12.4 | -7.7 | -21.9 | -10.7 | -6.0 | -18.8 | -15.9 | · | |
| Earnings Yield | -11.2% | -16.0% | -5.8% | -11.0% | -25.9% | -7.6% | · | · |
损益表 11
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $38M | $28M | |
| SG&A Expense | $18M | $17M | $15M | $18M | $26M | $20M | $20M | $18M | $19M | $15M | $13M | $14M | $15M | $12M | $12M | $12M | |
| Operating Expenses | $160M | $160M | $114M | $132M | $127M | $114M | $114M | $116M | $94M | $81M | $62M | $62M | $78M | $64M | $50M | $40M | |
| Other Non-op | $4.0K | $798.0K | $-54.0K | $250.0K | $1M | $1M | $-1M | $629.0K | $28.0K | $-3M | $1M | $20.0K | $464.0K | $-2M | $793.0K | $354.0K | |
| Pretax Income | $-153M | $-151M | $-109M | $-126M | $-120M | $-106M | $-111M | $-109M | $-87M | $-75M | $-52M | $-58M | $-74M | $-63M | $-48M | $-40M | |
| Income Tax | $0 | $-3M | $2M | $594.0K | $913.0K | $584.0K | $152.0K | $78.0K | $77.0K | $232.0K | $-108.0K | $454.0K | $-11.0K | $387.0K | $261.0K | $352.0K | |
| Net Income | $-153M | $-148M | $-111M | $-127M | $-121M | $-106M | $-111M | $-109M | $-87M | $-75M | $-51M | $-59M | $-74M | $-63M | $-48M | $-40M | |
| EPS (Basic) | $-0.75 | $-0.72 | $-0.61 | $-0.73 | $-0.71 | $-0.63 | $-0.76 | $-0.74 | $-0.60 | $-0.50 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | |
| EPS (Diluted) | $-0.75 | $-0.72 | $-0.61 | $-0.73 | $-0.71 | $-0.63 | $-0.76 | $-0.74 | $-0.60 | $-0.50 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | |
| Shares (Basic) | 205,545,373 | -343,608,976 | 181,513,386 | 173,643,829 | 170,872,994 | -287,903,505 | 146,922,338 | 146,468,991 | 146,085,729 | -268,081,363 | 144,523,034 | 131,155,642 | 130,503,264 | 128,574,190 | 116,572,820 | 116,557,508 | |
| Shares (Diluted) | 205,545,373 | -343,608,976 | 181,513,386 | 173,643,829 | 170,872,994 | -287,903,505 | 146,922,338 | 146,468,991 | 146,085,729 | -268,081,363 | 144,523,034 | 131,155,642 | 130,503,264 | 128,574,190 | 116,572,820 | 116,557,508 |
资产负债表 19
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $798M | $902M | $995M | $522M | $599M | $714M | $375M | $473M | $560M | $635M | $691M | $270M | $330M | $433M | $406M | $427M | |
| Receivables | $697.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $5M | $1M | $1M | $823.0K | $704.0K | $4M | $13M | |
| Prepaid Expense | $53M | $43M | $47M | $50M | $51M | $51M | $36M | $33M | $27M | $25M | $19M | $20M | $19M | $21M | $17M | $16M | |
| Current Assets | $851M | $949M | $1.04B | $574M | $652M | $768M | $413M | $507M | $589M | $666M | $711M | $291M | $350M | $454M | $426M | $456M | |
| PP&E (Net) | $351.0K | $443.0K | $531.0K | $632.0K | $737.0K | $844.0K | $752.0K | $671.0K | $565.0K | $462.0K | $376.0K | $304.0K | $325.0K | $362.0K | $312.0K | $328.0K | |
| Other Non-current Assets | $961.0K | $8M | $9M | $9M | $9M | $8M | $8M | $8M | · | $0 | · | · | · | · | · | · | |
| Total Assets | $852M | $957M | $1.05B | $583M | $661M | $776M | $421M | $516M | $590M | $666M | $711M | $292M | $351M | $456M | $428M | $459M | |
| Accounts Payable | $10M | $8M | $9M | $7M | $8M | $18M | $20M | $21M | $11M | $7M | $4M | $8M | $26M | $14M | $7M | $1M | |
| Accrued Liabilities | · | $97M | · | · | · | $51M | $48M | $46M | $34M | $41M | $28M | $32M | $24M | $26M | $23M | $19M | |
| Current Liabilities | $117M | $104M | $66M | $63M | $53M | $69M | $68M | $67M | $45M | $49M | $32M | $40M | $51M | $41M | $32M | $21M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $306.0K | $614.0K | $919.0K | |
| Total Liabilities | $117M | $104M | $66M | $63M | $53M | $69M | $68M | $67M | $45M | $49M | $32M | $40M | $51M | $42M | $32M | $22M | |
| Common Stock | $20.0K | $20.0K | $20.0K | $17.0K | $16.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | |
| Paid-in Capital | $2.63B | $2.60B | $2.58B | $2.00B | $1.97B | $1.95B | $1.48B | $1.47B | $1.46B | $1.44B | $1.43B | $950M | $940M | $920M | $841M | $833M | |
| Retained Earnings | $-1.90B | $-1.75B | $-1.60B | $-1.49B | $-1.36B | $-1.24B | $-1.13B | $-1.02B | $-913M | $-826M | $-750M | $-699M | $-640M | $-507M | $-444M | $-396M | |
| AOCI | $725.0K | $730.0K | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $-600.0K | $513.0K | $582.0K | $1M | $-1M | $-263.0K | |
| Stockholders' Equity | $735M | $853M | $986M | $520M | $609M | $707M | $353M | $449M | $545M | $618M | $679M | $252M | $300M | $415M | $396M | $436M | |
| Liabilities + Equity | $852M | $957M | $1.05B | $583M | $661M | $776M | $421M | $516M | $590M | $666M | $711M | $292M | $351M | $456M | $428M | $459M | |
| Shares Outstanding | 206,264,878 | 203,940,353 | 203,316,885 | 174,532,710 | 171,069,176 | 170,111,593 | 147,203,565 | 146,565,049 | 146,195,673 | 145,582,999 | 145,094,052 | 131,442,024 | 130,565,429 | 129,260,254 | 116,614,088 | 116,524,158 |
现金流 8
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $11M | $13M | $13M | $19M | $12M | $12M | $13M | $13M | $10M | $10M | $11M | $11M | $9M | $8M | $8M | |
| Operating Cash Flow | $-124M | $-95M | $-92M | $-103M | $-117M | $-111M | $-100M | $-89M | $-76M | $-60M | $-47M | $-60M | $-47M | $-46M | $-20M | $-66M | |
| CapEx | · | $8.0K | $0 | $0 | $0 | $201.0K | $180.0K | $196.0K | $182.0K | $150.0K | $131.0K | $34.0K | $45.0K | $98.0K | $31.0K | $42.0K | |
| Investing Cash Flow | · | $-8.0K | $0 | $0 | $0 | $-201.0K | $-180.0K | $-196.0K | $-182.0K | $-150.0K | $-131.0K | $-34.0K | $-45.0K | $-98.0K | $-31.0K | $-42.0K | |
| Stock Issued | · | $0 | · | · | · | $450M | · | · | · | · | · | · | · | $70M | · | · | |
| Financing Cash Flow | $20M | $4M | $565M | $25M | $3M | $451M | $2M | $730.0K | $686.0K | $2M | $470M | $148.0K | $890.0K | $71M | $0 | $21.0K | |
| Net Change in Cash | $-104M | $-92M | $473M | $-77M | $-115M | $339M | $-98M | $-87M | $-75M | $-56M | $421M | $-60M | $-47M | $27M | $-21M | $-67M | |
| Free Cash Flow | · | · | · | · | $-117M | · | · | · | $-76M | · | · | · | $-47M | · | · | $-66M |
盈利能力 4
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | · | · | · | · | · | · | · | · | -575.6% | -1642.3% | -1818.9% | -2147.7% | -4153.2% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -576.8% | -1629.6% | -1819.1% | -2134.5% | -4130.6% | · | |
| ROA | -20.2% | · | -15.0% | -23.0% | -19.3% | · | -19.6% | -27.0% | -18.5% | · | -8.8% | -16.3% | -18.3% | -12.7% | -9.6% | -9.5% | |
| ROE | -22.8% | · | -16.5% | -26.1% | -20.9% | · | -21.5% | -31.1% | -20.6% | · | -9.4% | -18.1% | -20.1% | -13.8% | -10.3% | -10.1% |
流动性与偿付能力 2
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | · | 15.7 | 9.1 | 12.3 | · | 6.0 | 7.6 | 13.1 | · | 22.1 | 7.2 | 6.8 | 11.0 | 13.4 | 21.5 | |
| Quick Ratio | 6.8 | · | 15.0 | 8.3 | 11.4 | · | 5.5 | 7.1 | 12.5 | · | 21.6 | 6.7 | 6.4 | 10.5 | 12.9 | 20.7 |
效率 2
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | 10.3 | 1.4 | 0.6 | 8.4 | 0.6 | · |
估值 (TTM) 10
| 指标 | 趋势 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | · | $20M | $20M | $20M | · | $20M | $20M | $20M | · | $20M | $12M | $8M | $4M | $1M | · | |
| Net Income TTM | $-511M | · | $-469M | $-467M | $-428M | · | $-359M | $-306M | $-271M | · | $-247M | $-244M | $-225M | $-193M | $-167M | $-150M | |
| Market Cap | $7.95B | · | $5.17B | $2.81B | $2.74B | · | $3.65B | $4.18B | $3.86B | · | $6.11B | $5.05B | $2.48B | $2.29B | $651M | $454M | |
| P/E | -13.8 | · | -9.0 | -5.5 | -5.7 | · | -10.1 | -13.3 | -13.3 | · | -22.5 | -20.0 | -10.4 | -11.0 | -3.8 | -2.8 | |
| P/S | 407.3 | · | 264.9 | 144.2 | 140.3 | · | 186.9 | 214.1 | 197.8 | · | 313.3 | 430.0 | 303.4 | 559.9 | 563.9 | · | |
| P/B | 10.8 | · | 5.2 | 5.4 | 4.5 | · | 10.3 | 9.3 | 7.1 | · | 9.0 | 20.0 | 8.3 | 5.5 | 1.6 | 1.0 | |
| P / Tangible Book | 10.8 | · | 5.2 | 5.4 | 4.5 | · | 10.3 | 9.3 | 7.1 | · | 9.0 | 20.0 | 8.3 | 5.5 | 1.6 | 1.0 | |
| P / Cash Flow | -63.9 | · | · | · | -23.3 | · | · | · | -50.7 | · | · | · | -52.3 | · | · | -6.9 | |
| P / FCF | · | · | · | · | -23.3 | · | · | · | -50.5 | · | · | · | -52.2 | · | · | -6.9 | |
| Earnings Yield | -7.3% | · | -11.1% | -18.2% | -17.6% | · | -9.9% | -7.5% | -7.5% | · | -4.4% | -5.0% | -9.6% | -9.1% | -26.3% | -35.1% |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| 净收入 | $-506M | $-414M | $-259M | $-211M | $-157M |
| 稀释后每股收益 (EPS) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 |
资产负债表
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| 流动比率 | 9.1 | 11.2 | 13.7 | 9.3 | 11.5 |
| 速动比率 | 8.6 | 10.4 | 13.2 | 8.7 | 11.4 |
现金流
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-407M | $-377M | $-215M | $-188M | $-106M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 249 家申报者 · $3.3B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 48 (+6 与上一季度对比) | 20 (-3 与上一季度对比) | 70 (-23 与上一季度对比) | 73 (+31 与上一季度对比) | +8.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Deep Track Capital, LP | $359914548 | 9341151 | 10.96% | 股份 |
| FMR LLC | $347227467 | 9011873 | 10.58% | 股份 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $223666650 | 5805000 | 6.81% | 股份 |
| BAKER BROS. ADVISORS LP | $209419027 | 5435220 | 6.38% | 股份 |
| STATE STREET CORP | $177893203 | 4617005 | 5.42% | 股份 |
| TCG Crossover Management, LLC | $171766278 | 4457988 | 5.23% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $150671912 | 3910509 | 4.59% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $140198379 | 3638681 | 4.27% | 股份 |
| RTW INVESTMENTS, LP | $122442522 | 3177849 | 3.73% | 股份 |
| Two Seas Capital LP | $121311898 | 3148505 | 3.69% | 股份 |
| JENNISON ASSOCIATES LLC | $99673911 | 2586917 | 3.04% | 股份 |
| ADAR1 Capital Management, LLC | $89802487 | 2330716 | 2.74% | 股份 |
| Woodline Partners LP | $76130233 | 1975869 | 2.32% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $74678244 | 1937765 | 2.27% | 股份 |
| ARMISTICE CAPITAL, LLC | $66888080 | 1736000 | 2.04% | 股份 |
| MORGAN STANLEY | $53652331 | 1392482 | 1.63% | 股份 |
| Alpine Global Management, LLC | $52978748 | 1375000 | 1.61% | 股份 |
| PERCEPTIVE ADVISORS LLC | $52299967 | 1357383 | 1.59% | 股份 |
| GOLDMAN SACHS GROUP INC | $49893306 | 1294921 | 1.52% | 股份 |
| D. E. Shaw & Co., Inc. | $44568961 | 1156734 | 1.36% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39397426 | 1022513 | 1.20% | 股份 |
| BANK OF AMERICA CORP /DE/ | $38642893 | 1002930 | 1.18% | 股份 |
| Aberdeen Group plc | $33021366 | 857030 | 1.01% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $28003604 | 726800 | 0.85% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $26223210 | 680592 | 0.80% | 股份 |
| Logos Global Management LP | $25622450 | 665000 | 0.78% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23853769 | 619096 | 0.73% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $21740398 | 564246 | 0.66% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $18262604 | 473984 | 0.56% | 股份 |
| Pictet Asset Management Holding SA | $17814692 | 462359 | 0.54% | 股份 |
| ARMISTICE CAPITAL, LLC | $15412000 | 400000 | 0.47% | 买入期权 |
| MILLENNIUM MANAGEMENT LLC | $12663963 | 328678 | 0.39% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $12332336 | 320071 | 0.38% | 股份 |
| JANE STREET GROUP, LLC | $11959712 | 310400 | 0.36% | 买入期权 |
| HighVista Strategies LLC | $10706447 | 277873 | 0.33% | 股份 |
| STEMPOINT CAPITAL LP | $10654585 | 276527 | 0.32% | 股份 |
| Tetragon Partners GP Ltd | $9861137 | 255934 | 0.30% | 股份 |
| Soleus Capital Management, L.P. | $9709560 | 252000 | 0.30% | 股份 |
| SUPERSTRING CAPITAL MANAGEMENT LP | $8028419 | 208368 | 0.24% | 股份 |
| Granahan Investment Management, LLC | $7951513 | 206372 | 0.24% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7050990 | 183000 | 0.21% | 买入期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6288096 | 163200 | 0.19% | 卖出期权 |
| CITADEL ADVISORS LLC | $6169539 | 160123 | 0.19% | 股份 |
| ALGERT GLOBAL LLC | $6158635 | 159840 | 0.19% | 股份 |
| DAFNA Capital Management LLC | $5761160 | 149524 | 0.18% | 股份 |
| PLATINUM INVESTMENT MANAGEMENT LTD | $5574174 | 144671 | 0.17% | 股份 |
| Erste Asset Management GmbH | $5564695 | 144500 | 0.17% | 股份 |
| MARSHALL WACE, LLP | $5490063 | 142488 | 0.17% | 股份 |
| Man Group plc | $5398669 | 140116 | 0.16% | 股份 |
| Nuveen Asset Management, LLC | $5305957 | 214209 | 0.16% | 股份 |
| Swiss National Bank | $5112931 | 132700 | 0.16% | 股份 |
| Informed Momentum Co LLC | $4903304 | 127273 | 0.15% | 股份 |
| Jump Financial, LLC | $4815750 | 124987 | 0.15% | 股份 |
| Bank of New York Mellon Corp | $4784578 | 124178 | 0.15% | 股份 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $4705000 | 122100 | 0.14% | 股份 |
| Nuveen, LLC | $4397660 | 114136 | 0.13% | 股份 |
| CITIGROUP INC | $4285307 | 111220 | 0.13% | 股份 |
| RHUMBLINE ADVISERS | $4128322 | 107146 | 0.13% | 股份 |
| Cubist Systematic Strategies, LLC | $4073712 | 252712 | 0.12% | 股份 |
| Affinity Asset Advisors, LLC | $3853000 | 100000 | 0.12% | 股份 |
| XTX Topco Ltd | $3496906 | 90758 | 0.11% | 股份 |
| Trexquant Investment LP | $3079318 | 79920 | 0.09% | 股份 |
| DME Capital Management, LP | $3028843 | 78610 | 0.09% | 股份 |
| Squarepoint Ops LLC | $2996440 | 77769 | 0.09% | 股份 |
| TD Asset Management Inc | $2949086 | 76540 | 0.09% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $2902802 | 116860 | 0.09% | 股份 |
| Atom Investors LP | $2857809 | 74171 | 0.09% | 股份 |
| Rafferty Asset Management, LLC | $2752198 | 71430 | 0.08% | 股份 |
| CITADEL ADVISORS LLC | $2596922 | 67400 | 0.08% | 卖出期权 |
| BlackRock, Inc. | $2535890 | 65816 | 0.08% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $2496397 | 64791 | 0.08% | 股份 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $2460950 | 63871 | 0.07% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2342064 | 94286 | 0.07% | 股份 |
| CITADEL ADVISORS LLC | $2227034 | 57800 | 0.07% | 买入期权 |
| BANQUE PICTET & CIE SA | $2203531 | 57190 | 0.07% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $2201797 | 57145 | 0.07% | 股份 |
| HighTower Advisors, LLC | $2161687 | 56104 | 0.07% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $2139494 | 55528 | 0.07% | 股份 |
| CAPITAL FUND MANAGEMENT S.A. | $1982291 | 51448 | 0.06% | 股份 |
| SIMPLEX TRADING, LLC | $1968112 | 51080 | 0.06% | 股份 |
| DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. | $1918987 | 49805 | 0.06% | 股份 |
| MetLife Investment Management, LLC | $1914055 | 49677 | 0.06% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1871402 | 48570 | 0.06% | 股份 |
| Alchemi Wealth, LLC | $1791645 | 46500 | 0.05% | 股份 |
| Quantinno Capital Management LP | $1772573 | 46005 | 0.05% | 股份 |
| STATE OF WISCONSIN INVESTMENT BOARD | $1572140 | 40803 | 0.05% | 股份 |
| Vanguard Global Advisers, LLC | $1433316 | 37200 | 0.04% | 股份 |
| BARCLAYS PLC | $1410969 | 36620 | 0.04% | 股份 |
| PROFUND ADVISORS LLC | $1406730 | 36510 | 0.04% | 股份 |
| FOX RUN MANAGEMENT, L.L.C. | $1341884 | 34827 | 0.04% | 股份 |
| Cinctive Capital Management LP | $1326781 | 34435 | 0.04% | 股份 |
| Invesco Ltd. | $1309635 | 33990 | 0.04% | 股份 |
| China Universal Asset Management Co., Ltd. | $1307130 | 33925 | 0.04% | 股份 |
| STRS OHIO | $1263784 | 32800 | 0.04% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1190308 | 30893 | 0.04% | 股份 |
| Gotham Asset Management, LLC | $1159753 | 30100 | 0.04% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $1158019 | 30055 | 0.04% | 股份 |
| NOMURA HOLDINGS INC | $1152047 | 29900 | 0.04% | 买入期权 |
| NOMURA HOLDINGS INC | $1152047 | 29900 | 0.04% | 卖出期权 |
| Jain Global LLC | $992302 | 25754 | 0.03% | 股份 |
公司内部人士 19 位内幕人士 · 11 位高管 · 10 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Eric Venker | Chief Executive Officer | 2026年7月1日 M | 254280 | 0 | 1 | $-118980 |
| Peter Salzmann | Chief Executive Officer | 2020年5月15日 A | — | 0 | 0 | $0 |
| Roderick Wong, M.D. | Chief Executive Officer | 2019年12月11日 P | 902498 | 0 | 0 | $0 |
| Tiago Girao | Chief Financial Officer | 2026年7月23日 S | 240798 | 0 | 2 | $-647615 |
| Connealy Pamela Yanchik | Chief Financial Officer | 2020年5月15日 A | — | 0 | 0 | $0 |
| Melanie Gloria | Chief Operating Officer | 2026年7月8日 S | 222357 | 0 | 4 | $-759137 |
| Jay S Stout | Chief Technology Officer | 2026年7月23日 S | 205341 | 0 | 7 | $-1780771 |
| Christopher Van Tuyl | Chief Legal Officer | 2026年7月8日 S | 179391 | 0 | 5 | $-823806 |
| Julia G. Butchko | Chief Dev. & Tech. Officer | 2020年5月15日 A | — | 0 | 0 | $0 |
| Bradford W Middlekauff | General Counsel | 2020年5月15日 A | — | 0 | 0 | $0 |
| Robert K Zeldin | Chief Medical Officer | 2019年12月18日 A | — | 0 | 0 | $0 |
| Atul Pande | 董事 | 2026年7月24日 M | 116731 | 0 | 3 | $-167745 |
| Andrew J. Fromkin | 董事 | 2026年5月28日 M | 74382 | 0 | 2 | $-7438111 |
| Roivant Sciences Ltd. | 董事 | 2025年12月12日 P | 113317007 | 1 | 0 | $349999986 |
| Douglas J. Hughes | 董事 | 2020年5月15日 A | 24700 | 0 | 0 | $0 |
| Frank Torti | 董事 | 2020年5月15日 A | 28400 | 0 | 0 | $0 |
| George V Migausky | 董事 | 2020年5月15日 A | 24700 | 0 | 0 | $0 |
| Myrtle S Potter | 董事 | 2019年12月18日 A | — | 0 | 0 | $0 |
| Health Sciences Holdings, LLC | 10% 所有者 | 2019年12月18日 J | — | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. ×11 申报 | 2025年12月12日 | 55.90% | 修订 | — | SEC |
| Roderick Wong, M.D. | 2019年12月27日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 43 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| GURU · Global X Funds | 1.11% | 23885 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.77% | 147047 NS | 2026年4月30日 | N-PORT |
| BBC · ETFis Series Trust I | 0.76% | 10446 NS | 2026年4月30日 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.56% | 11172 SH | 2026年8月8日 | 每日 |
| MEDI · Harbor ETF Trust | 0.55% | 5589 NS | 2026年4月30日 | N-PORT |
| BIB · ProShares Trust | 0.34% | 7523 NS | 2026年5月31日 | N-PORT |
| IBB · iShares Trust | 0.25% | 595351 SH | 2026年8月8日 | 每日 |
| IWO · iShares Trust | 0.21% | 772368 SH | 2026年8月8日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.19% | 91474 SH | 2026年8月8日 | 每日 |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.11% | 30298 NS | 2026年4月30日 | N-PORT |
| ISCG · iShares Trust | 0.11% | 26918 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.11% | 2158220 SH | 2026年8月8日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 490917 SH | 2026年8月8日 | 每日 |
| BKSE · BNY Mellon ETF Trust | 0.09% | 2751 NS | 2026年4月30日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.09% | 1086290 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.07% | 3836 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.07% | 35319 NS | 2026年4月30日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.06% | 173 NS | 2026年5月31日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.05% | 371189 NS | 2026年5月31日 | N-PORT |
| ISCB · iShares Trust | 0.05% | 3864 SH | 2026年8月8日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.05% | 36680 SH | 2026年8月8日 | 每日 |
| VFMO · VANGUARD WELLINGTON FUND | 0.05% | 28526 SH | 2026年8月8日 | 每日 |
| UWM · ProShares Trust | 0.04% | 3000 NS | 2026年5月31日 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.04% | 1883385 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.04% | 199146 SH | 2026年8月8日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 0.03% | 36741 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 887661 SH | 2026年8月8日 | 每日 |
| URTY · ProShares Trust | 0.03% | 3037 NS | 2026年5月31日 | N-PORT |
| WSML · iShares Trust | 0.03% | 4310 SH | 2026年8月8日 | 每日 |
| ONEQ · Fidelity Commonwealth Trust | 0.02% | 55075 NS | 2026年5月31日 | N-PORT |
| SMLF · iShares Trust | 0.02% | 16182 SH | 2026年8月8日 | 每日 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 2816 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.01% | 76 NS | 2026年5月31日 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0.01% | 18937 SH | 2026年8月8日 | 每日 |
| ITOT · iShares Trust | 0.00% | 116586 SH | 2026年8月8日 | 每日 |
| IWV · iShares Trust | 0.00% | 23762 SH | 2026年8月8日 | 每日 |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 44851 NS | 2026年5月31日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 2310 NS | 2026年4月30日 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0.00% | 128 NS | 2026年5月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2600899 SH | 2026年8月8日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 67319 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7098 SH | 2026年8月8日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.00% | 18 NS | 2026年4月30日 | N-PORT |